Table 7

Incremental effectiveness and costs from our base-case analyses (drotrecogin alfa compared to placebo)

Model

Incremental Cost (95% CI)

Incremental effectiveness (LYG)

% simulations where drotrecogin alfa has a lower effectiveness than placebo

All patients

$11,024

($8,670, $13,341)

0.344

(-0.807, 1.476)

27%

APACHE II ≥ 25

$13,612

($9,785, $17,421)

1.191

(-0.082, 2.417)

3%

CI = confidence interval

LYG = life-years gained

Costa and Brophy BMC Anesthesiology 2007 7:5   doi:10.1186/1471-2253-7-5